A giant deal involving Atlanta-based animal health company Merial has gotten a final green light from U.S. regulators.
In the deal, announced last June, Boehringer Ingelheim has acquired Sanofi’s animal care subsidiary, Merial, valued at $13.53 billion, and Sanofi took over Boehringer Ingelheim’s consumer health care business unit, valued at $7.98 billion, as well as cash compensation of $5.54 billion.
The Federal Trade Commission on Feb. 24 approved a final order okaying the deal. The FTC…
A giant deal involving Atlanta-based animal health company Merial has gotten a final green light from U.S. regulators.
In the deal, announced last June, Boehringer Ingelheim has acquired Sanofi’s animal care subsidiary, Merial, valued at $13.53 billion, and Sanofi took over Boehringer Ingelheim’s consumer health care business unit, valued at $7.98 billion, as well as cash compensation of $5.54 billion.
The Federal Trade Commission on Feb. 24 approved a final order okaying the deal. The FTC…